Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
BOEHRINGER INGELHEIM ITALIA S P A	ITALY FLORENCE

International Classification(s)

• A61K:PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOS....
• C07D:HETEROCYCLIC COMPOUNDS

• [Classification Symbol]

• [Patents Count]

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Berta, Daniela Gavina	Milan, IT	2	15
Ferrara, Marco	San Donato Milanese, IT	59	498
Gerlach, Kai	Mlttelbiberach, DE	55	264
Gutsche, Kirsten	Laupheim, DE	1	0
Hobson, Scott	Mittelbiberach, DE	9	8
Mueller-Vieira, Ursula	Biberach an der Riß, DE	3	1
Runge, Frank	Biberach an der Riß, DE	21	248
Semple, Graeme	San Diego, US	47	619
Vintonyak, Viktor	Warthausen, DE	18	162
Xiong, Yifeng	San Diego, US	70	982

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
3.5 Year Payment	$1600.00	$800.00	$400.00	Apr 15, 2028
7.5 Year Payment	$3600.00	$1800.00	$900.00	Apr 15, 2032
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Apr 15, 2036

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 3.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge - 7.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

DATE PUBLISHED	PUBLICATION/PATENT NO.	PUBLICATION TYPE
October 15, 2024	US,12115157,B2   US12115157B2	GRANTED PATENT AS SECOND PUBLICATION
April 27, 2023	US,20230131465,A1   US20230131465A1	FIRST PUBLISHED PATENT APPLICATION

Full Text

US Patent Application No: 12115157

3-phenoxyazetidin-1-yl-heteroaryl pyrrolidine derivatives and the use thereof as medicament

---

 

Legal Events